In vitro studies of uterine sarcoma and cervical cancers have demonstrated PGRMC1 to enhance the epithelial mesenchymal transition phenotypes, promote chemoresistance, and have a possible role in progression of metastasis [65, 66]. The gene discussed is PGRMC1; the disease is uterine corpus sarcoma.